Description

In 2010, Frost & Sullivan launched an end-user survey to examine the use of genomics technologies, including next-generation sequencing, by researchers in academic and government laboratories, at pharmaceutical and biotechnology companies, and in hospital and clinical laboratories. This analysis is based on results from researchers from the various end-user groups and investigates topics—such as current and future adoption of sequencing technologies; brands, applications, sample types and formats preferred; species researched, and laboratory budgets. The survey screened for respondents with decision-making roles from laboratories within the United States and segmented them by their awareness and adoption of next-generations sequencing.